APA (7th ed.) Citation

Xue, W., Wang, T., Yao, J., Wu, W., Chen, D., Yan, B., . . . Yan, J. (2023). Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Bioengineering & Translational Medicine, 8(6), 1. https://doi.org/10.1002/btm2.10586

Chicago Style (17th ed.) Citation

Xue, Weisong, et al. "Use of Patient‐derived Tumor Organoid Platform to Predict the Benefit of Postoperative Adjuvant Chemotherapy for Poor Responders to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer." Bioengineering & Translational Medicine 8, no. 6 (2023): 1. https://doi.org/10.1002/btm2.10586.

MLA (9th ed.) Citation

Xue, Weisong, et al. "Use of Patient‐derived Tumor Organoid Platform to Predict the Benefit of Postoperative Adjuvant Chemotherapy for Poor Responders to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer." Bioengineering & Translational Medicine, vol. 8, no. 6, 2023, p. 1, https://doi.org/10.1002/btm2.10586.